Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.
- DOI
- 10.1007/s10549-026-08121-1
- Published
- 2026 Nov 9
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-026-08121-1,
title = {Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.},
author = {Hwang YH and Lee SB and Kim J and Chung IY and Ko B and Kim HJ and Lee JW and Son BH and Yoo TR},
year = {2026},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-026-08121-1},
url = {https://doi.org/10.1007/s10549-026-08121-1}
}RIS
TY - JOUR TI - Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer. AU - Hwang YH AU - Lee SB AU - Kim J AU - Chung IY AU - Ko B AU - Kim HJ AU - Lee JW AU - Son BH AU - Yoo TR PY - 2026 JO - Breast cancer research and treatment DO - 10.1007/s10549-026-08121-1 UR - https://doi.org/10.1007/s10549-026-08121-1 ER -
APA
YH, H., SB, L., J, K., IY, C., B, K., HJ, K., JW, L., BH, S., & TR, Y. (2026). Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-026-08121-1
Source records
- pubmed · retrieved 2026-11-10T19:11:45.476Z